Investigation is ongoing by the Nigeria Center for Disease Control (NCDC) over the blood clotting in some persons who received the first jab of the AstraZeneca vaccine.
Chikwe Ihekweazu, the Director General, spoke to the press at the Presidential Task Force (PTF) on COVID-19 briefing.
Recall that on Tuesday, the European Medicines Agency announced that there’s a causal link between AstraZeneca’s jab and rare blood clots.
The Head of Health Threats and Vaccine Strategy, Marco Cavaleri, told Rome’s Il Messaggero newspaper that a definitive statement will be released this week.
Ihekweazu said the government was aware of the blood clotting in individuals in Europe.
“Those investigations are still ongoing. Not all European countries are adopting the vaccines for their populations,” he said.
The DG assured that Nigeria has a system to measure and monitor any side effects.
Ihekweazu said the National Agency for Food Drugs Administration and Control (NAFDAC) and the National Primary Health Care Development Agency (NPHCDA) are on top of the situation.
“Actions will be taken after data and circumstances are fully evaluated,” the NCDC chief added.